ClinicalTrials.govpublic full text
Trilaciclib in Patients Receiving Sacituzumab Govitecan-hziy for Triple Negative Breast Cancer
triple negative breast cancer, tnbc, trodelvy, myelosuppression, interventional, phase2
This document is indexed with metadata only — full text is not available in the archive for this record.
Open the official source ↗Related documents
Record · ID 868605
Retrieved via
Conceptio — every document is proof-bundled with source, license, and retrieval metadata.